Semaglutide vs liraglutide: dose and weight loss
Both are approved GLP-1 receptor agonists for weight management, injected weekly and daily respectively. Same receptor, same class, one generation apart.
Reference
Comparisons
Both sides get the same rows, the same sourcing, and no verdict. What we can tell you is how they differ; which one belongs in your situation is a conversation for you and a clinician.
BPC-157 vs Thymosin Beta-4
The two halves of the repair pairing, compared instead of combined. This is also where the TB-500 naming confusion does the most damage.
Ipamorelin vs GHRP-2
Two ghrelin-receptor secretagogues doing the same job. Selectivity is what separates them: one raises growth hormone and little else, the other raises several things at once.
Retatrutide vs semaglutide
One receptor against three, and a finished approval against a trial programme still running. The largest reported effect in the class, set beside the most established one.
GHK-Cu vs AHK-Cu
Two copper peptides sold for different tissue. Both carry copper, and that is why running them together is a question, not a default.
CJC-1295 vs sermorelin: half-life and schedule
CJC-1295 and sermorelin are GHRH analogues acting on the same receptor, and how long each survives in the body is the whole of the difference. It sets both the schedule and the shape of what comes out.
Tesamorelin vs HGH
Ask the body to release its own growth hormone, or supply it from outside. The choice decides how much say the body's own feedback still has.
5-Amino-1MQ vs MOTS-c
Two metabolic compounds approached from opposite ends: an oral small molecule that inhibits an enzyme, and a mitochondrial peptide. Almost no human data between them.
Semaglutide vs cagrilintide
Two different satiety pathways, usually discussed as a pair rather than a choice. One is an approved drug on its own; the other is mostly studied alongside it.
Tirzepatide vs survodutide
Two dual agonists that picked different second receptors, GIP in one case and glucagon in the other, and that sit at very different stages of evidence.
MK-677 vs HGH
An oral secretagogue against injected growth hormone. Cheaper, needle-free and indirect on one side. The hormone itself, dosed in IU, on the other.
Semaglutide vs tirzepatide
Both are once-weekly incretin agonists approved for weight management. The difference is how many receptors each one acts on, and what that does to the dosing scale.
BPC-157 vs TB-500
Two research peptides discussed for tissue repair. Both rest on animal evidence, and they differ in proposed mechanism and in dose scale.
CJC-1295 vs ipamorelin
The most compared pair in this category, and the comparison is slightly wrong-headed. They act on different receptors and are usually run together rather than chosen between.
Tesamorelin vs CJC-1295
Two GHRH analogues acting on the same receptor, separated by the largest evidence gap on this site. One completed a phase 3 programme and holds an approval; the other has neither.
MK-677 vs ipamorelin
Same receptor, opposite shapes. One is an oral small molecule producing sustained elevation; the other is an injected peptide producing a short pulse. Only one of them has a trial that was stopped early.
Tirzepatide vs retatrutide
Two and three receptors respectively. Retatrutide reported the larger weight reduction; tirzepatide has a completed phase 3 programme and an approval. This is a different kind of claim.
NAD+ vs Epitalon
Two longevity compounds with very different problems: one has a delivery problem, the other has a replication problem.
PT-141 vs Melanotan II
The same parent molecule taken in two directions. One was refined until it stopped tanning you and got approved; the other kept every receptor it started with and never did.
Testosterone vs hCG
One replaces the hormone. The other asks the testes to keep making it. That difference decides what happens to fertility, and it is the reason they are often prescribed together rather than instead of each other.
Gonadorelin vs hCG
Both are used to keep the testes working during testosterone therapy, and they act at different points in the chain. One prompts the pituitary; the other bypasses it entirely.
Semax vs Selank
Two Russian nasal peptides that get discussed as a pair and are reached for at opposite ends of a problem: one for focus, the other for anxiety.
Thymosin alpha-1 vs Thymosin beta-4
They share a name and almost nothing else. One is an immune modulator with approvals in more than thirty countries; the other is a repair peptide still in trials. Sharing a prefix has done more harm here than in any other pair on this site.
Orforglipron vs semaglutide
The same receptor, reached two different ways. One is a daily tablet that is not a peptide at all; the other is a weekly injection. The trade is convenience against a longer record.
Mazdutide vs tirzepatide
Two dual agonists that picked different second receptors. Tirzepatide added GIP; mazdutide added glucagon, which does something GIP does not.
PT-141 vs afamelanotide
Both are melanocortin agonists derived from the same parent peptide, used for entirely different things. One is for sexual desire, the other for light tolerance in a rare blood disorder.
Noopept vs Semax: oral tablet or nasal peptide
Two Russian nootropics reached for by the same people. One is a tablet, the other a nasal spray, and only one of them is a peptide.
Next
Other ways to weigh things up
- Compare a pair we have not written aboutThe same attributes side by side for any two compounds in the catalogue, generated from the profiles.
- Run together rather than chosen betweenSeveral of these pairs are more often combined than compared, and those have their own pages.
- Check a pair you are runningWhat our profiles record about any two compounds, in both directions.
- What each one costsPer-milligram prices across every vendor we read, which is often the deciding factor.